Cost-effectiveness of Extracorporeal Life Support Treatment

NCT ID: NCT02837419

Last Updated: 2019-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2020-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control.

Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Health related Quality of life EQ-5D

Quality of Care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to intensive care
* Treated with extracorporeal life support

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center Groningen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Willem Dieperink

research coordinator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

walter m van den Bergh, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

department of critical care, UMCG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Medical Center Groningen

Groningen, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wim Dieperink, PhD

Role: CONTACT

+31503619838 ext. 49838

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wim Dieperink, PhD

Role: primary

+31503619838

References

Explore related publications, articles, or registry entries linked to this study.

Jolink FEJ, Onrust M, Dos Reis Miranda D, Mandigers L, Delnoij T, Maas JJ, Raasveld SJ, Vlaar APJ, Donker DW, Scholten E, de Metz J, van den Brule J, Kuijpers M, Vermeulen KM, van der Voort PHJ, van den Bergh WM, Oude Lansink-Hartgring A; Dutch Extracorporeal Life Support (ECLS) Study Group. Five Years After Extracorporeal Membrane Oxygenation: A Prospective Cohort Study of Health-Related Quality of Life and Patient Outcomes. Crit Care Med. 2025 Oct 15. doi: 10.1097/CCM.0000000000006900. Online ahead of print.

Reference Type DERIVED
PMID: 41091003 (View on PubMed)

Oude Lansink-Hartgring A, Dos Reis Miranda D, Donker DW, Maas JJ, Delnoij T, Kuijpers M, van den Brule J, Scholten E, Endeman H, Vlaar APJ, van den Bergh WM; Dutch ECLS study group. Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands. BMC Health Serv Res. 2018 Mar 9;18(1):172. doi: 10.1186/s12913-018-2964-6.

Reference Type DERIVED
PMID: 29523153 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Dutch ECLS/2014/QoL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of eCPR Survivors
NCT05339854 UNKNOWN